January 11, 2025 10:00 AM Eastern Standard Time IRVINE, Calif.–(BUSINESS WIRE)–Immunis, Inc., a clinical-stage biotech developing multi-active biologics for age and disease-related immune dysregulation, has closed a $25 million Series A-1 financing round to fund…
According to filings with the U.S. Securities and Exchange Commission, Smart Health Diagnostics dba SmartHealth Dx is raising up to $10,000,000.00 in new funding. The federal securities law requires the notice to be filed by…
According to filings with the U.S. Securities and Exchange Commission, Huupe is raising up to $18,936,500.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Paul Anton played a key…
According to filings with the U.S. Securities and Exchange Commission, Nano Banc is raising up to $25,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Scott Racusin played a…
According to filings with the U.S. Securities and Exchange Commission, Mixed-Signal Devices is raising up to $17,400,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Avi Madisetti played a…
According to filings with the U.S. Securities and Exchange Commission, Clearflow is raising up to $3,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Hannah Beathard played a key…
According to filings with the U.S. Securities and Exchange Commission, Eledon Pharmaceuticals is raising up to $49,999,010.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Paul Little played a…
According to filings with the U.S. Securities and Exchange Commission, Tally Surgical is raising up to $7,189,998.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Brian Stewart played a…
According to filings with the U.S. Securities and Exchange Commission, NileBuilt is raising up to $75,000,000.00 in new funding. Sources indicate that as part of senior management Executive, Manoj Krishan played a key role in…
According to filings with the U.S. Securities and Exchange Commission, Allevion Therapeutics is raising up to $1,475,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Shawn Moaddeb played a…